0001104659-19-028074.txt : 20190509 0001104659-19-028074.hdr.sgml : 20190509 20190509100142 ACCESSION NUMBER: 0001104659-19-028074 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190509 DATE AS OF CHANGE: 20190509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gosebruch Henry O CENTRAL INDEX KEY: 0001659625 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38535 FILM NUMBER: 19809162 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064-6092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptinyx Inc. CENTRAL INDEX KEY: 0001674365 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474626057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 MAPLE AVENUE STREET 2: SUITE 4300 CITY: EVANSTON STATE: IL ZIP: 60201 BUSINESS PHONE: 847-871-0377 MAIL ADDRESS: STREET 1: 909 DAVIS STREET STREET 2: SUITE 600 CITY: EVANSTON STATE: IL ZIP: 60201 4 1 a4.xml 4 X0306 4 2019-05-07 0 0001674365 Aptinyx Inc. APTX 0001659625 Gosebruch Henry O C/O APTINYX INC. 909 DAVIS STREET, SUITE 600 EVANSTON IL 60201 1 0 0 0 Common Stock 2019-05-07 4 P 0 3420 3.75 A 3420 D Common Stock 2019-05-08 4 P 0 96580 3.86 A 100000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.785 to $3.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. /s/ Ashish Khanna, as Attorney-in-Fact 2019-05-09